||Recombinant Human RPS27A (Accession # CAA44911) was produced in E. coli-derived.
|Predicted N Terminal:
||Supplied as a 0.2 µm filtered solution in PBS.
||Bioassay data are not available.Able to significantly enhance neurite outgrowth when immobilized at 6-12 µg/mL.
||Recombinant Human RPS27A has a calculated MW of 13 kDa. In SDS-PAGE migrates as 13 kDa, reducing conditions.
||>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).